AGEN (STOCKS)
Agenus Inc.
$3.259400
-0.040600 (-1.23%)
Prev close: $3.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Garo H. Armen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $135.34M
- Employees
- 316
- P/E (TTM)
- 1.98
- P/B (TTM)
- -0.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.00 | $2.14 | -2.1420 | -100.00% |
|
Dec 2025 (Q4)
|
$-0.31 | $-1.07 | +0.7634 | +71.05% |
|
Sep 2025 (Q3)
|
$1.94 | $2.02 | -0.0796 | -3.94% |
|
Jun 2025 (Q2)
|
$-1.00 | $1.38 | -2.3804 | -172.44% |
Financial Statements
| Revenues | $123.87M |
| Benefits Costs and Expenses | $61.37M |
| Cost Of Revenue | $885.00K |
| Costs And Expenses | $85.53M |
| Nonoperating Income/Loss | -$2.16M |
| Operating Expenses | $114.79M |
| Depreciation and Amortization | $7.38M |
| Research and Development | $69.64M |
| Other Operating Expenses | $43.97M |
| Operating Income/Loss | $8.20M |
| Income/Loss From Continuing Operations After Tax | $62.49M |
| Income/Loss From Continuing Operations Before Tax | $62.49M |
| Income/Loss From Equity Method Investments | -$27.70M |
| Net Income/Loss | $62.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$2.11M |
| Net Income/Loss Attributable To Parent | $62.39M |
| Net Income/Loss Available To Common Stockholders, Basic | $64.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.66 |
| Diluted Earnings Per Share | $1.59 |
| Basic Average Shares | 99,494,000 |
| Diluted Average Shares | 100,730,000 |
| Assets | $186.46M |
| Current Assets | $95.28M |
| Prepaid Expenses | $4.19M |
| Other Current Assets | $91.10M |
| Noncurrent Assets | $91.17M |
| Fixed Assets | $14.95M |
| Intangible Assets | $2.96M |
| Other Non-current Assets | $73.27M |
| Liabilities | $414.44M |
| Current Liabilities | $249.24M |
| Accounts Payable | $71.08M |
| Other Current Liabilities | $178.15M |
| Noncurrent Liabilities | $165.20M |
| Long-term Debt | $30.19M |
| Other Non-current Liabilities | $135.01M |
| Equity | -$227.98M |
| Equity Attributable To Noncontrolling Interest | -$6.76M |
| Equity Attributable To Parent | -$221.22M |
| Liabilities And Equity | $186.46M |
| Net Cash Flow From Operating Activities | -$87.53M |
| Net Cash Flow From Operating Activities, Continuing | -$87.53M |
| Net Cash Flow From Investing Activities | $70.09M |
| Net Cash Flow From Investing Activities, Continuing | $70.09M |
| Net Cash Flow From Financing Activities | $32.01M |
| Net Cash Flow From Financing Activities, Continuing | $32.01M |
| Net Cash Flow | $14.57M |
| Net Cash Flow, Continuing | $14.57M |
| Other Comprehensive Income/Loss | $1.03M |